• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.

作者信息

Shytle R Douglas, Silver Archie A, Sheehan Kathy H, Sheehan David V, Sanberg Paul R

机构信息

Center for Aging and Brain Repair, Department of Neurosurgery, University of South Florida College of Medicine, 12901 Bruce B. Downs Boulevard, Tampa, FL 33613, USA.

出版信息

Depress Anxiety. 2002;16(3):89-92. doi: 10.1002/da.10035.

DOI:10.1002/da.10035
PMID:12415531
Abstract
摘要

相似文献

1
Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.用于治疗情绪障碍的神经元烟碱受体抑制作用：美加明的初步对照证据
Depress Anxiety. 2002;16(3):89-92. doi: 10.1002/da.10035.
2
Mecamylamine (Targacept).美加明（Targacept公司生产）。
IDrugs. 2006 Mar;9(3):205-17.
3
(S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD).（S）-（+）-美加明（TC-5214）：一种神经元烟碱受体调节剂作为重度抑郁症（MDD）的辅助治疗进入III期试验。
ACS Chem Neurosci. 2010 Aug 18;1(8):530-1. doi: 10.1021/cn100070s.
4
Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders.美加明 - 一种烟碱型乙酰胆碱受体拮抗剂，具有治疗神经精神疾病的潜力。
Expert Opin Pharmacother. 2009 Nov;10(16):2709-21. doi: 10.1517/14656560903329102.
5
Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?α3β4烟碱型受体拮抗作用是否是减轻吗啡依赖性的一种策略？
Eur J Pharmacol. 2005 Apr 25;513(3):207-18. doi: 10.1016/j.ejphar.2005.03.005. Epub 2005 Apr 14.
6
Nicotinic acetylcholine receptors as targets for antidepressants.作为抗抑郁药靶点的烟碱型乙酰胆碱受体
Mol Psychiatry. 2002;7(6):525-35. doi: 10.1038/sj.mp.4001035.
7
Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine).抽动秽语综合征中共病的双相情感障碍对烟碱受体拮抗剂美加明（异坎胺）有反应。
Biol Psychiatry. 2000 Nov 15;48(10):1028-31. doi: 10.1016/s0006-3223(00)00945-8.
8
Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans.毒蕈碱和烟碱受体对人类客体和空间n-回溯工作记忆的调节作用
Pharmacol Biochem Behav. 2005 Jul;81(3):575-84. doi: 10.1016/j.pbb.2005.04.010.
9
Treatment of Tourette's syndrome with mecamylamine.用美加明治疗抽动秽语综合征。
Lancet. 1998 Aug 29;352(9129):705-6. doi: 10.1016/S0140-6736(05)60822-7.
10
Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.竞争性神经元烟碱受体拮抗剂：药物研发的新方向。
J Pharmacol Exp Ther. 2001 Aug;298(2):395-402.

引用本文的文献

1
What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders.我们从伊博加因中获得的启示：α3β4 烟碱型乙酰胆碱受体抑制剂作为物质使用障碍的治疗方法。
J Med Chem. 2023 Jan 12;66(1):107-121. doi: 10.1021/acs.jmedchem.2c01562. Epub 2022 Nov 28.
2
Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization.罗帕尼坦（SUVN-911），一种用于治疗抑郁症的 α4β2 烟碱型乙酰胆碱受体拮抗剂：药理学、行为学和神经化学特征。
Psychopharmacology (Berl). 2022 Jul;239(7):2215-2232. doi: 10.1007/s00213-022-06108-6. Epub 2022 Mar 17.
3
The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [F]ASEM.
健康老年人中 alpha7 烟碱型乙酰胆碱受体的分布：应用[F]ASEM 的体内正电子发射断层扫描研究。
Neuroimage. 2018 Jan 15;165:118-124. doi: 10.1016/j.neuroimage.2017.10.009. Epub 2017 Oct 7.
4
Hippocampal α7 nicotinic ACh receptors contribute to modulation of depression-like behaviour in C57BL/6J mice.海马体 α7 型烟碱型乙酰胆碱受体参与调节 C57BL/6J 小鼠的抑郁样行为。
Br J Pharmacol. 2018 Jun;175(11):1903-1914. doi: 10.1111/bph.13769. Epub 2017 Apr 8.
5
Cognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial Perspective.认知功能障碍、情感状态与尼古丁成瘾易感性：多因素视角
Front Psychiatry. 2016 Sep 21;7:160. doi: 10.3389/fpsyt.2016.00160. eCollection 2016.
6
Anxiolytic- and antidepressant-like effects of the methadone metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP).美沙酮代谢产物2-乙基-5-甲基-3,3-二苯基-1-吡咯啉（EMDP）的抗焦虑和抗抑郁样作用。
Neuropharmacology. 2016 Feb;101:46-56. doi: 10.1016/j.neuropharm.2015.09.012. Epub 2015 Sep 11.
7
The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profile.强效且选择性的α4β2*/α6*-烟碱型乙酰胆碱受体部分激动剂 2-[5-[5-((S)氮杂环丁烷-2-基甲氧基)-3-吡啶基]-3-异噁唑基]乙醇在动物模型中表现出抗抑郁样行为，且具有良好的 ADME-tox 特性。
Pharmacol Res Perspect. 2014 Apr;2(2):e00026. doi: 10.1002/prp2.26. Epub 2014 Mar 12.
8
Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: prefrontal cortex level of BDNF protein and monoaminergic neurotransmitters.烟碱拮抗剂美加明在大鼠抑郁模型中的行为效应：前额叶皮质脑源性神经营养因子蛋白和单胺能神经递质水平
Psychopharmacology (Berl). 2015 Mar;232(6):1095-105. doi: 10.1007/s00213-014-3745-5. Epub 2014 Oct 15.
9
Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine.海马体中5-羟色胺1A受体的表达对于社交压力恢复力以及烟碱部分激动剂金雀花碱诱导的抗抑郁样效应是必需的。
Neuropsychopharmacology. 2015 Mar;40(4):938-46. doi: 10.1038/npp.2014.269. Epub 2014 Oct 7.
10
Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.靶向α4β2-烟碱型乙酰胆碱受体的新型抗抑郁药的最新进展。
J Med Chem. 2014 Oct 23;57(20):8204-23. doi: 10.1021/jm401937a. Epub 2014 Jul 2.